This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Majmudar, N. G. Articles by Ford, G. A. Search for Related Content PubMed PubMed Citation Articles by Majmudar, N. G. Articles by Ford, G. A.

Effects of the Menopause, Gender, and Estrogen Replacement Therapy on Vascular Nitric Oxide Activity

Departments of Pharmacological Sciences (N.G.M., G.A.F.), Obstetrics (S.C.R.), and Medicine (N.G.M., G.A.F.), University of Newcastle Upon Tyne, NE2 4HH Newcastle Upon Tyne, United Kingdom

Address all correspondence and requests for reprints to: Dr. G. A. Ford, Wolfson Unit of Clinical Pharmacology, University of Newcastle Upon Tyne, NE2 4HH Newcastle Upon Tyne, United Kingdom. E-mail: g.a.ford{at}ncl.ac.uk

Changes in vascular nitric oxide (NO) activity may contribute to cardiovascular risk. We determined the effect of the menopause, gender, and estrogen replacement therapy on arterial vascular NO activity. Vascular NO activity and sensitivity were determined in 15 healthy premenopausal women (mean age, 48 yr), 12 postmenopausal women (51 yr), and 14 men (51 yr). The effects of 14 days of estrogen replacement therapy (625 µg conjugated estrogens) were studied in 20 healthy postmenopausal women (60 yr). Forearm blood flow responses to brachial arterial infusions of L-N^G-monomethyl-arginine (L-NMMA), norepinephrine, glyceryl trinitrate (GTN), and serotonin were determined using venous occlusion plethysmography. Constrictor responses to L-NMMA were reduced in postmenopausal women (82 ± 14, summary response, mean ± SEM) and men (89 ± 6) compared to premenopausal women (118 ± 10; P < 0.05). Constrictor responses to norepinephrine were increased in males (125 ± 13) compared to premenopausal (81 ± 8) and postmenopausal (88 ± 16) women (P < 0.05). No differences were observed in GTN or serotonin responsiveness. Constrictor responses to L-NMMA increased after estrogen replacement (132 ± 7 vs. 89 ± 14; P < 0.05), with no change in norepinephrine, GTN, or serotonin responses. The menopause and male gender were associated with reduced arterial NO activity. Two weeks of estrogen replacement therapy restored vascular NO activity to premenopausal levels. Changes in vascular NO activity may contribute to changes in cardiovascular risk associated with male gender, postmenopausal status, and estrogen replacement therapy. Increased -adrenoceptor responsiveness may contribute to increased cardiovascular risk in males.

This article has been cited by other articles:

				X.-D. Fu, M. Flamini, A. M. Sanchez, L. Goglia, M. S. Giretti, A. R. Genazzani, and T. Simoncini Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin Mol. Hum. Reprod., April 1, 2008; 14(4): 225 - 234. [Abstract] [Full Text] [PDF]

				M. Coylewright, J. F. Reckelhoff, and P. Ouyang Menopause and Hypertension: An Age-Old Debate Hypertension, April 1, 2008; 51(4): 952 - 959. [Full Text] [PDF]

				R. Rossi, A. Nuzzo, G. Origliani, and M. G. Modena Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 997 - 1002. [Abstract] [Full Text] [PDF]

				K. Kublickiene, E. Svedas, B.-M. Landgren, M. Crisby, N. Nahar, H. Nisell, and L. Poston Small Artery Endothelial Dysfunction in Postmenopausal Women: In Vitro Function, Morphology, and Modification by Estrogen and Selective Estrogen Receptor Modulators J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6113 - 6122. [Abstract] [Full Text] [PDF]

				A. Page, H. Reich, J. Zhou, V. Lai, D. C. Cattran, J. W. Scholey, and J. A. Miller Endothelial Nitric Oxide Synthase Gene/Gender Interactions and the Renal Hemodynamic Response to Angiotensin II J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3053 - 3060. [Abstract] [Full Text] [PDF]

				V L Clifton, R Crompton, M A Read, P G Gibson, R Smith, and I M R Wright Microvascular effects of corticotropin-releasing hormone in human skin vary in relation to estrogen concentration during the menstrual cycle J. Endocrinol., July 1, 2005; 186(1): 69 - 76. [Abstract] [Full Text] [PDF]

				R. P. Brandes, I. Fleming, and R. Busse Endothelial aging Cardiovasc Res, May 1, 2005; 66(2): 286 - 294. [Abstract] [Full Text] [PDF]

				R. Rossi, E. Cioni, A. Nuzzo, G. Origliani, and M. G. Modena Endothelial-Dependent Vasodilation and Incidence of Type 2 Diabetes in a Population of Healthy Postmenopausal Women Diabetes Care, March 1, 2005; 28(3): 702 - 707. [Abstract] [Full Text] [PDF]

				R. Rossi, E. Chiurlia, A. Nuzzo, E. Cioni, G. Origliani, and M. G. Modena Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1636 - 1640. [Abstract] [Full Text] [PDF]

				J. C. Sullivan, E. D. Loomis, M. Collins, J. D. Imig, E. W. Inscho, and J. S. Pollock Age-related alterations in NOS and oxidative stress in mesenteric arteries from male and female rats J Appl Physiol, October 1, 2004; 97(4): 1268 - 1274. [Abstract] [Full Text] [PDF]

				J. Rogers and D. D. Sheriff Role of estrogen in nitric oxide- and prostaglandin-dependent modulation of vascular conductance during treadmill locomotion in rats J Appl Physiol, August 1, 2004; 97(2): 756 - 763. [Abstract] [Full Text] [PDF]

				E. Nikander, M. Metsa-Heikkila, A. Tiitinen, and O. Ylikorkala Evidence of a Lack of Effect of a Phytoestrogen Regimen on the Levels of C-Reactive Protein, E-Selectin, and Nitrate in Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5180 - 5185. [Abstract] [Full Text] [PDF]

				A. P. McKee, D. A. Van Riper, C. A. Davison, and H. A. Singer Gender-dependent modulation of alpha 1-adrenergic responses in rat mesenteric arteries Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1737 - H1743. [Abstract] [Full Text] [PDF]

				H. Grasemann, K. S. van's Gravesande, R. Buscher, N. Knauer, E. S. Silverman, L. J. Palmer, J. M. Drazen, and F. Ratjen Endothelial Nitric Oxide Synthase Variants in Cystic Fibrosis Lung Disease Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 390 - 394. [Abstract] [Full Text] [PDF]

				K. L. Chambliss and P. W. Shaul Estrogen Modulation of Endothelial Nitric Oxide Synthase Endocr. Rev., October 1, 2002; 23(5): 665 - 686. [Abstract] [Full Text] [PDF]

				K. L. Moreau, A. J. Donato, D. R. Seals, F. A. Dinenno, S. D. Blackett, G. L. Hoetzer, C. A. Desouza, and H. Tanaka Arterial intima-media thickness: site-specific associations with HRT and habitual exercise Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1409 - H1417. [Abstract] [Full Text] [PDF]

				A. Persu, M. S. Stoenoiu, T. Messiaen, S. Davila, C. Robino, O. El-Khattabi, M. Mourad, S. Horie, O. Feron, J. -L. Balligand, et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease Hum. Mol. Genet., February 1, 2002; 11(3): 229 - 241. [Abstract] [Full Text] [PDF]

				M. A. van Dijk, A. M. Kamper, S. van Veen, J. H. M. Souverijn, and G. J. Blauw Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2152 - 2157. [Abstract] [Full Text] [PDF]

				A. Scuteri, A. J.G. Bos, L. J. Brant, L. Talbot, E. G. Lakatta, and J. L. Fleg Hormone Replacement Therapy and Longitudinal Changes in Blood Pressure in Postmenopausal Women Ann Intern Med, August 21, 2001; 135(4): 229 - 238. [Abstract] [Full Text] [PDF]